Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study
Clinical trial NCT07246330 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07246330
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-15
- Primary completion
- 2027-12-15
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.